Crossmark

The gliadin-CFTR connection: new perspectives for the treatment of celiac disease

Crossref DOI link: https://doi.org/10.1186/s13052-019-0627-9

Published Online: 2019-03-21

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maiuri, Luigi https://orcid.org/0000-0002-4962-9016
Villella, Valeria R.

Raia, Valeria

Kroemer, Guido
License Information

Text and Data Mining valid from 2019-03-21
More Information

Article History

Received: 12 February 2019

Accepted: 27 February 2019

First Online: 21 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests. A patent application by LM is pending (filing date, July 26, 2017. No 102017000085714). GK is a scientific co-founder of Samsara therapeutics.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.